Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 17.41 USD -25.47% Market Closed
Market Cap: 284.5m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Biostem Technologies Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biostem Technologies Inc
Total Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Biostem Technologies Inc
OTC:BSEM
Total Receivables
$11.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Receivables
$16.2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Receivables
$14.9B
CAGR 3-Years
8%
CAGR 5-Years
23%
CAGR 10-Years
17%
Pfizer Inc
NYSE:PFE
Total Receivables
$15.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
4%
Merck & Co Inc
NYSE:MRK
Total Receivables
$12.2B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Total Receivables
$12.1B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
13%

See Also

What is Biostem Technologies Inc's Total Receivables?
Total Receivables
11.4m USD

Based on the financial report for Dec 31, 2023, Biostem Technologies Inc's Total Receivables amounts to 11.4m USD.

What is Biostem Technologies Inc's Total Receivables growth rate?
Total Receivables CAGR 1Y
3 691%

Over the last year, the Total Receivables growth was 3 691%.

Back to Top